Since the inception of Modern Trader, a core editorial theme has centered on the wisdom and power of crowds. Editorial emphasis has focused on companies and projects engaged in the collection and analysis of information.
Thursday, 8 December 2016
Last updated 15 hours ago
Jul 18 2008 | 10:35am ET
New York- and Chicago-based Meadowbrook Capital Management has launched its second hedge fund, a long/short all-cap offering, to complement its existing small- and micro-cap fund.
The Meadowbrook Beta Neutral Fund, managed by Afsin Alp, launched on July 1 with $10 million, investing in healthcare technology sector. The fund charges a 2% management fee and a 20% performance fee.
Meadowbrook’s existing Meadowbrook Opportunity Fund currently manages some $35 million in assets.